Novel Drug Promising as Metformin Add-on

MedPage Today -- Adding dapagliflozin, an investigational selective sodium-glucose cotransporter-2 (SGLT2) inhibitor, to metformin may improve glycemic control in diabetic patients who aren't responsive to metformin monotherapy.